TIAN; Ye Edward

Patent Applications and Registrations

Patent applications and USPTO patent grants for TIAN; Ye Edward.The latest application filed is for "substituted fused heteroaromatic bicyclic compounds as kinase inhibitors and the use thereof".

Company Profile

8.19.26

TIAN; Ye Edward - Shanghai CN
Tian; Ye Edward - Jiangsu CN
TIAN; Ye Edward - Nanjing CN
Tian; Ye Edward - Jamestown NC
Tian; Ye Edward - Canton MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Fused Heteroaromatic Bicyclic Compounds As Kinase Inhibitors And The Use Thereof App 20220267332 - CAI; Suixiong ; et al.	2022-08-25
Substituted Pyrazoloquinazolinone Compounds And Application Thereof App 20220259211 - CAI; Sui Xiong ; et al.	2022-08-18
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 11,358,955 - Cai , et al. June 14, 2	2022-06-14
8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones Grant 11,345,711 - Cai , et al. May 31, 2	2022-05-31
Imidazo[1,2-b]pyrimido[4,5-d]pyridazin-5(6H)-ones and the use thereof Grant 11,345,710 - Cai , et al. May 31, 2	2022-05-31
Substituted Fused Heteroaromatic Tricyclic Compounds as Kinase Inhibitors and The Use Thereof App 20210128535 - CAI; Suixiong ; et al.	2021-05-06
Substituted fused heteroaromatic compounds as kinase inhibitors and the use thereof Grant 10,874,670 - Cai , et al. December 29, 2	2020-12-29
8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES App 20200385394 - CAI; Sui Xiong ; et al.	2020-12-10
8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones Grant 10,703,759 - Cai , et al.	2020-07-07
N-(3-heteroarylaryl)-4-arylarylcarboxamides and analogs as hedgehog pathway inhibitors and use thereof Grant 10,676,468 - Cai , et al.	2020-06-09
IMIDAZO[1,2-b]PYRIMIDO[4,5-d]PYRIDAZIN-5(6H)-ONES AND THE USE THEREOF App 20200131192 - CAI; Suixiong ; et al.	2020-04-30
Substituted Fused Heteroaromatic Compounds as Kinase Inhibitors and the Use Thereof App 20190358225 - CAI; Suixiong ; et al.	2019-11-28
8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES App 20190308984 - CAI; Sui Xiong ; et al.	2019-10-10
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof App 20190270732 - CAI; Sui Xiong ; et al.	2019-09-05
Application Of Hedgehog Pathway Inhibitor In Treating Fibrosis Diseases App 20190255042 - CAI; Sui Xiong ; et al.	2019-08-22
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 10,316,027 - Cai , et al.	2019-06-11
1-(Arylmethyl)quinazoline-2,4(1H,3H)-Diones as PARP Inhibitors and the Use Thereof App 20180215741 - CAI; Sui Xiong ; et al.	2018-08-02
1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 9,926,304 - Cai , et al. March 27, 2	2018-03-27
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof Grant 9,290,460 - Cai , et al. March 22, 2	2016-03-22
3-aryl-6-aryl-[1,2,4]triazolo[4,3-.alpha.]pyridines as inhibitors of cell proliferation and the use thereof Grant 9,199,983 - Cai , et al. December 1, 2	2015-12-01
1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof Grant 9,102,631 - Cai , et al. August 11, 2	2015-08-11
Rage fusion proteins and methods of use Grant 8,877,192 - Mjalli , et al. November 4, 2	2014-11-04
1-(Arylmethyl)-5,6,7,8-tetrahydroquinazolline-2,4-diones and Analogs and the Use Thereof App 20140275711 - Cai; Suixiong ; et al.	2014-09-18
1-(Arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP Inhibitors and the Use Thereof App 20140023642 - Cai; Sui Xiong ; et al.	2014-01-23
3-Aryl-6-aryl-[1,2,4]triazolo[4,3-alpha]pyridines as Inhibitors of Cell Proliferation and the Use Thereof App 20130280245 - Cai; Suixiong ; et al.	2013-10-24
Nucleic acid molecules encoding rage fusion proteins Grant 8,344,120 - Mjalli , et al. January 1, 2	2013-01-01
Rage Fusion Proteins And Methods Of Use App 20120171202 - MJALLI; ADNAN M.M. ; et al.	2012-07-05
Rage Fusion Proteins, Formulations And Methods Of Use Thereof App 20110282035 - Mjalli; Adnan M.M. ; et al.	2011-11-17
Rage Fusion Proteins And Methods Of Use App 20110244516 - Mjalli; Adnan M.M. ; et al.	2011-10-06
RAGE fusion proteins, formulations, and methods of use thereof Grant 7,981,424 - Mjalli , et al. July 19, 2	2011-07-19
Rage Fusion Proteins And Methods Of Use App 20110124102 - Mjalli; Adnan M.M. ; et al.	2011-05-26
Immunoglobulin Fusion Proteins and Methods of Making App 20110110945 - Mjalli; Adnan M.M. ; et al.	2011-05-12
Rage fusion proteins Grant 7,901,688 - Mjalli , et al. March 8, 2	2011-03-08
Rage Fusion Proteins and Methods of Use App 20090060925 - Mjalli; Adnan M.M. ; et al.	2009-03-05
Immunoglobulin fusion proteins and methods of making App 20080199467 - Mjalli; Adnan M. M. ; et al.	2008-08-21
RAGE fusion proteins, formulations, and methods of use thereof App 20080045455 - Mjalli; Adnan M.M. ; et al.	2008-02-21
RAGE fusion proteins and methods of use App 20060078562 - Mjalli; Adnan M.M. ; et al.	2006-04-13
Rage fusion proteins and methods of use App 20060030527 - Mjalli; Adnan M.M. ; et al.	2006-02-09
VEGF responsive cell-based assay for determining VEGF bioactivity Grant 6,787,323 - Batley , et al. September 7, 2	2004-09-07
VEGF responsive cell-based assay for determining VEGF bioactivity App 20020110830 - Batley, Brian Lee ; et al.	2002-08-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.